Edwards Lifesciences Corporation (NYSE: EW) announced at EuroPCR 2009 the results from its first post-market study of consecutively enrolled Edwards ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE